Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1325 of 3284 entries
View as:

REported Outcomes in COPD With Trixeo in Real worlD in Germany

Phase: N/A Priority: Normal
NCT ID: NCT05311306 Org: User:
Start: 03/15/22 End: 07/16/24 Due: 07/16/25

Efficacy and Safety of Tezepelumab in Participants With Severe Chronic Rhinosinusitis With Nasal Polyposis

Phase: N/A Priority: Normal
NCT ID: NCT04851964 Org: User:
Start: 04/22/21 End: 12/11/24 Due: 12/11/25

Acalabrutinib Study With Best Supportive Care Versus Best Supportive Care in Subjects Hospitalized With COVID-19.

Phase: N/A Priority: Normal
NCT ID: NCT04380688 Org: User:
Start: 06/13/20 End: 11/16/20 Due: 11/16/21

Single and Multiple Ascending Doses of AZD1981 in Japan

Phase: N/A Priority: Normal
NCT ID: NCT00698282 Org: User:
Start: 08/31/08 End: 10/31/08 Due: 10/31/09

Assessment of Long-term Safety in Patients With Non-cancer-related Pain and Opioid-induced Constipation

Phase: N/A Priority: Normal
NCT ID: NCT01336205 Org: User:
Start: 04/30/11 End: 12/31/12 Due: 12/31/13

GALLEX 9: Safety and Tolerability of Oral Tesaglitazar When Added to Insulin Therapy in Patients With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00229710 Org: User:
Start: 02/28/05 End: 12/31/06 Due: 12/31/07

Assess the Efficacy, Safety and Tolerability of Gefitinib (Iressa® 250mg) as Maintenance Therapy in Locally Advanced or Metastatic (Stage IIIB/IV) Non Small Cell Lung Cancer (NSCLC)

Phase: N/A Priority: Normal
NCT ID: NCT00770588 Org: User:
Start: 09/30/08 End: 02/28/11 Due: 02/28/12

Volrustomig Priming Regimens Exploratory Phase II Platform Study

Phase: N/A Priority: Normal
NCT ID: NCT06448754 Org: User:
Start: 08/27/24 End: 06/30/27 Due: 06/30/28

Open, Randomized, Two Way Crossover Study Comparing the Effect of Esomeprazole Adminstered Orally and iv

Phase: N/A Priority: Normal
NCT ID: NCT00626262 Org: User:
Start: 07/31/02 End: 10/31/02 Due: 10/31/03

A Study Comparing Exenatide With Basal Insulin in Achieving a Target HbA1c With Minimum Weight Gain in Type 2 Diabetes Patients

Phase: N/A Priority: Normal
NCT ID: NCT00360334 Org: User:
Start: 06/30/06 End: 04/30/08 Due: 04/30/09

Efficacy and Safety Study of Symbicort® Turbuhaler® Versus Oxis® Turbuhaler® in Chronic Obstructive Pulmonary Disease (COPD) Patients

Phase: N/A Priority: Normal
NCT ID: NCT01069289 Org: User:
Start: 01/31/10 End: 03/31/11 Due: 03/31/12

A Study to Assess the Relative Bioavailability and Safety of Different Formulations of AZD4831 in Fasted State in Healthy Volunteers.

Phase: N/A Priority: Normal
NCT ID: NCT05457270 Org: User:
Start: 08/11/22 End: 10/17/22 Due: 10/17/23

A Study of IRESSA in Relapsed and Refractory Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00298688 Org: User:
Start: 09/30/04 End: 03/31/07 Due: 03/31/08

Statins and Risk of Myocardial Infarction in Real Life in France

Phase: N/A Priority: Normal
NCT ID: NCT00679575 Org: User:
Start: 03/31/07 End: 11/30/10 Due: 11/30/11

Seroquel in Bipolar Depression Versus SSRI

Phase: N/A Priority: Normal
NCT ID: NCT00119652 Org: User:
Start: 05/31/05 End: 05/31/07 Due: 05/31/08

Descriptive Study of the Incidence of Malignancy in Severe Asthma Patients Receiving Benralizumab and Other Biologic Therapy, a Post Authorization Safety Study

Phase: N/A Priority: Normal
NCT ID: NCT04991805 Org: User:
Start: 02/26/21 End: 04/05/24 Due: 04/05/25

ZAP, US. Zomig for Appropriate for Primary Care

Phase: N/A Priority: Normal
NCT ID: NCT00637286 Org: User:
Start: 07/31/04 End: 05/31/05 Due: 05/31/06

AZD5069 Neutrophil Function Study

Phase: N/A Priority: Normal
NCT ID: NCT01480739 Org: User:
Start: 12/31/11 End: 07/31/12 Due: 07/31/13

ABCSG 8 - Adjuvant Treatment in Patients With Hormone Receptor-positive Breast Cancer With Good to Moderate Differentiation.

Phase: N/A Priority: Normal
NCT ID: NCT00291759 Org: User:
Start: 01/31/96 End: 06/30/09 Due: 06/30/10

To Explore the Treatment Effect of Various Commercially Available Statins on Patients With Hyperlipidemia

Phase: N/A Priority: Normal
NCT ID: NCT00726362 Org: User:
Start: 12/31/07 End: 11/30/09 Due: 11/30/10

Omepral® Tablets Special Clinical Experience Investigation in Patients With Erosive Esophagitis

Phase: N/A Priority: Normal
NCT ID: NCT00859287 Org: User:
Start: 06/30/07 End: 07/31/08 Due: 07/31/09

Association of COPD Maintenance Medication Adherence With Resource Use and Cost Among COPD Patients

Phase: N/A Priority: Normal
NCT ID: NCT03359122 Org: User:
Start: 06/07/18 End: 08/20/18 Due: 08/20/19

A Global Study of Volrustomig (MEDI5752) for Participants With Unresected Locally Advanced Head and Neck Squamous Cell Carcinoma Following Definitive Concurrent Chemoradiotherapy

Phase: N/A Priority: Normal
NCT ID: NCT06129864 Org: User:
Start: 12/14/23 End: 05/23/30 Due: 05/23/31

ACS Registry - A Non-interventional Study to Estimate the Rates of Outcomes in ACS Patients in Moscow

Phase: N/A Priority: Normal
NCT ID: NCT03654157 Org: User:
Start: 03/25/18 End: 10/19/21 Due: 10/19/22

REal World Information on Cardiovascular Drug Management Patterns in Acute Coronary Syndrome paTients

Phase: N/A Priority: Normal
NCT ID: NCT02001545 Org: User:
Start: 02/28/14 End: 09/30/14 Due: 09/30/15